JournalScan
| The first 150 words of the full text of this article appear below. |
ISCHAEMIC HEART DISEASE

Although suggestive small trials have been done, no large scale randomised trials have been undertaken to assess routine perioperative ß blockade to reduce cardiovascular risk. This study of "real life" assessed 782 969 patients, of whom 663 635 (85%) had no recorded contraindications to ß blockers, and 122 338 of whom (18%) received such treatment during the first two hospital days. High risk patients made up 44%, with a revised cardiac risk index (RCRI) score of 4 or higher. This index stratifies the risk of perioperative cardiac events according to the type of surgery and the presence or absence of a history of ischaemic heart disease, congestive heart failure, cerebrovascular disease, preoperative treatment with insulin, and a preoperative serum creatinine concentration > 2.0 mg/dl (176.8 µmol/l). The relation between perioperative ß blocker treatment and the risk of death varied directly with cardiac risk; among the 580 665 patients with an
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
